Vaccines against dengue: a review of current candidate vaccines at advanced development stages

被引：35

作者：

Hombach, Joachim ^{[1
]}

机构：

[1] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland

来源：

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH | 2007年 / 21卷 / 04期

关键词：

dengue; Aedes aegypti; flavivirus; dengue hemorrhagic fever; viral vaccines;

D O I：

10.1590/S1020-49892007000300011

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：254 / 260

页数：7

共 23 条

[1] Live attenuated tetravalent dengue vaccine [J].

Bhamarapravati, N ;

Sutee, Y .

VACCINE, 2000, 18 :44-47

[2] Development of a live attenuated dengue virus vaccine using reverse genetics [J].

Blaney, JE ;

Durbin, AP ;

Murphy, BR ;

Whitehead, SS .

VIRAL IMMUNOLOGY, 2006, 19 (01) :10-32

[3] Replication of chimeric yellow fever virus-Dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells [J].

Brandler, S ;

Brown, N ;

Ermak, TH ;

Mitchell, F ;

Parsons, M ;

Zhang, ZX ;

Lang, J ;

Monath, TP ;

Guirakhoo, F .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (01) :74-81

[4] Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels [J].

Clark, DV ;

Mammen, MP ;

Nisalak, A ;

Puthimethee, V ;

Endy, TP .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (06) :786-791

[5] rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers [J].

Durbin, AP ;

Whitehead, SS ;

McArthur, J ;

Perreault, JR ;

Blaney, JE ;

Thumar, B ;

Murphy, BR ;

Karron, RA .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :710-718

[6] Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine [J].

Edelman, R ;

Wasserman, SS ;

Bodison, SA ;

Putnak, RJ ;

Eckels, KH ;

Tang, D ;

Kanesa-Thasan, N ;

Vaughn, DW ;

Innis, BL ;

Sun, W .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (06) :48-60

[7] Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates [J].

Guirakhoo, F ;

Pugachev, K ;

Zhang, Z ;

Myers, G ;

Levenbook, I ;

Draper, K ;

Lang, J ;

Ocran, S ;

Mitchell, F ;

Parsons, M ;

Brown, N ;

Brandler, S ;

Fournier, C ;

Barrere, B ;

Rizvi, F ;

Travassos, A ;

Nichols, R ;

Trent, D ;

Monath, T .

JOURNAL OF VIROLOGY, 2004, 78 (09) :4761-4775

[8] Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity [J].

Guirakhoo, Farshad ;

Kitchener, Scott ;

Morrison, Dennis ;

Forrat, Remi ;

McCarthy, Karen ;

Nichols, Richard ;

Yoksan, Sutee ;

Duan, Xiaochu ;

Ermak, Thomas H. ;

Kanesa-Thasan, Niranjian ;

Bedford, Philip ;

Lang, Jean ;

Quentin-Millet, Marie-Jose ;

Monath, Thomas P. .

HUMAN VACCINES, 2006, 2 (02) :60-67

[9]

HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268

[10] STUDIES ON PATHOGENESIS OF DENGUE INFECTION IN MONKEYS .1. CLINICAL LABORATORY RESPONSES TO PRIMARY INFECTION [J].

HALSTEAD, SB ;

SHOTWELL, H ;

CASALS, J .

JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (01) :7-14

← 1 2 3 →